Impact of the COVID-19 pandemic on specialty community practices: an oncology perspective

doi:10.37765/ajmc.2020.88569

Cited by 4 publications

(2 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Finally, reporting requirements to collect individuallevel ePROs and social determinants of health are well-intentioned but may involve considerable upfront investment that community practices (which are still recovering from the financial shock induced by the COVID-19 pandemic) cannot bear. 4 The result of all these factors? The EOM is unlikely to garner participation from smaller practices that lack sufficient infrastructure, practices that did not perform well in OCM due to high costs of care, and practices without experience in value-based care programs to determine their expected risk.…”

Section: Challenges With Selection Biasmentioning

confidence: 99%

“…This creates increased risk, particularly for first-time participants or smaller practices that lack existing practice management resources. Finally, reporting requirements to collect individual-level ePROs and social determinants of health are well-intentioned but may involve considerable upfront investment that community practices (which are still recovering from the financial shock induced by the COVID-19 pandemic) cannot bear …”

Section: Challenges With Selection Biasmentioning

confidence: 99%

See 1 more Smart Citation

Next-Generation Alternative Payment Models in Oncology—Will Precision Preclude Participation?

2023

View full text Add to dashboard Cite

show abstract

Section: Challenges With Selection Biasmentioning

confidence: 99%

Section: Challenges With Selection Biasmentioning

confidence: 99%

Next-Generation Alternative Payment Models in Oncology—Will Precision Preclude Participation?

2023

View full text Add to dashboard Cite

show abstract

Evaluating video-based consultations in routine clinical practice at a comprehensive cancer center

Mottet,

Hémar,

Enfedaque

et al. 2023

Acta Oncologica

View full text Add to dashboard Cite

Changes in the quality of cancer care as assessed through performance indicators during the first wave of the COVID-19 pandemic in 2020: a Scoping Review

Carvalho

Fernandes

Lange

et al. 2022

Preprint

View full text Add to dashboard Cite

Objectives: Summarize performance indicators used in the literature to evaluate the impact of the COVID-19 pandemic on cancer care (January-June 2020), and to assess changes in the quality of care as assessed via selected indicators. Methods: Scoping review. Indicators and their reported trends were collated following the cancer care pathway. Results: Database searches retrieved 6277 articles, 838 articles met the inclusion criteria, and 135 articles were included after full-text screening, from which 917 indicators were retrieved. Indicators assessing the diagnostic process showed a decreasing trend: from 33 indicators reporting on screening, 30 (91%) signalled a decrease during the pandemic (n=30 indicators, 91%). A reduction was also observed in the number of diagnostic procedures (n=64, 58%) and in the diagnoses (n=130, 89%). The proportion of diagnoses in the emergency setting and waiting times showed an increasing trend (n=8, 89% and n=14, 56%, respectively). Nine indicators (64%) showed stability in cancer stages distribution. A decreasing trend in the proportion of earliest stage cancers was reported by 63% of indicators (n=9), and 70% (n=43) of indicators showed an increasing trend in the proportion of advanced-stage cancers. Indicators reflecting the treatment process signalled a reduction in the number of procedures: 79% (n=82) of indicators concerning surgeries, 72% (n=41) of indicators assessing trends in radiotherapy, and 93% (n=40) of indicators related to systemic therapies. Modifications in cancer treatment were frequently reported: 64% (n=195) of indicators revealed changes in treatment. Ten indicators (83%) signalled a decreasing number of hospital admissions. Conclusion: Health systems struggled to ensure continuity of cancer care. As this pandemic keeps evolving, the trends reported over the first 6 months of 2020 provide an argument to monitor these changes closely. This information needs to be transparent, standardised, and timely, allowing to monitor quality and outcomes of care during crises and inform policy responses.

show abstract

Impact of the COVID-19 pandemic on specialty community practices: an oncology perspective

Cited by 4 publications

References 3 publications

Next-Generation Alternative Payment Models in Oncology—Will Precision Preclude Participation?

Next-Generation Alternative Payment Models in Oncology—Will Precision Preclude Participation?

Evaluating video-based consultations in routine clinical practice at a comprehensive cancer center

Changes in the quality of cancer care as assessed through performance indicators during the first wave of the COVID-19 pandemic in 2020: a Scoping Review

Contact Info

Product

Resources

About